The global pharmaceutical industry is going through challenging times. Drug pipelines are drying out, blockbusters are losing exclusivity, pressure on prices is increasing and new manufacturing and supply chain models are introduced as a result of new technologies.
The global pharmaceutical industry is going through challenging times. Drug pipelines are drying out, blockbusters are losing exclusivity, pressure on prices is increasing and new manufacturing and supply chain models are introduced as a result of new technologies.The global pharmaceutical industry is going through challenging times. Drug pipelines are drying out, blockbusters are losing exclusivity, pressure on prices is increasing and new manufacturing and supply chain models are introduced as a result of new technologies.
The global pharmaceutical industry is going through challenging times. Drug pipelines are drying out, blockbusters are losing exclusivity, pressure on prices is increasing and new manufacturing and supply chain models are introduced as a result of new technologies.
